Table 4 The main clinical and imaging features of the 40 WD patients comorbid with PCOS
Clinical feature | Total (n = 40) | Adolescent group (n = 18) | Reproductive age group (n = 22) | p | Normal level group(n = 18) | Elevated level group(n = 22) | p |
|---|---|---|---|---|---|---|---|
Neurologic | 32(80%) | 14(77.8%) | 18(81.8%) | 1.000 | 14(77.8%) | 18(81.8%) | 1.000 |
Hepatic | 40(100%) | 18(100%) | 22(100%) | - | 18(100%) | 22(100%) | - |
Psychiatric | 8(20%) | 5(27.8%) | 3(13.6%) | 0.430 | 3(16.7%) | 5(22.7%) | 0.709 |
Irregular menstruation | 40(100%) | 18(100%) | 22(100%) | - | 18(100%) | 22(100%) | - |
Hyperandrogenism | 20(50%) | 13(72.2%) | 7(31.8%) | 0.025 | 9(50%) | 11(50%) | 1.000 |
Polycystic ovarian morphology | 40(100%) | 18(100%) | 22(100%) | - | 11(100%) | 15(100%) | - |
Liver cirrhosis | 36(90%) | 15(83.3%) | 21(95.5%) | 0.310 | 15(83.3%) | 21(95.5%) | 0.310 |
Brain MRI abnormality | 31(77.5%) | 13(72.2%) | 18(81.8%) | 0.705 | 13(72.2%) | 18(81.8%) | 0.705 |